GeoVax Labs (GOVXW) News Today $0.13 0.00 (0.00%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic LeukemiaNovember 19 at 10:05 AM | stockhouse.comGeoVax Labs (NASDAQ:GOVXW) Shares Down 7.2% - Here's WhyNovember 16, 2024 | americanbankingnews.comNoble Financial Keeps Their Buy Rating on GeoVax Labs (GOVX)November 13, 2024 | markets.businessinsider.comGeoVax Labs, Inc. (NASDAQ:GOVX) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | msn.comThis GeoVax Labs Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For MondayNovember 12, 2024 | benzinga.comRocket Pharmaceuticals, Inc. (9IP1.F) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.comGeoVax Labs, Inc. (GOVX): A Hot Penny Stock On The MoveSeptember 4, 2024 | insidermonkey.comGeoVax Labs, Inc. (GOVXW)August 21, 2024 | au.finance.yahoo.comStock Market Today: Dow ends lower, S&P 500 snaps 8-day winning streak as comeback rally pausesAugust 21, 2024 | marketwatch.comEmergent Biosolutions, Bavarian Nordic, GeoVax And SIGA Technologies Shares Are Making Big Moves Thursday: What's Going On?August 15, 2024 | benzinga.comStrong Buy Rating for GeoVax Labs on Government Support and Promising Trial ProspectsAugust 9, 2024 | markets.businessinsider.comGeoVax Labs Inc.July 19, 2024 | barrons.comGeoVax to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024May 7, 2024 | finance.yahoo.comGeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 VaccineApril 4, 2024 | finance.yahoo.comGeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine CongressMarch 28, 2024 | finance.yahoo.comGeoVax Announces Multiple Patent Issuances and AllowancesFebruary 13, 2024 | finance.yahoo.comGeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine BoosterFebruary 6, 2024 | finance.yahoo.comTrading was temporarily halted for "GOVXW" at 07:01 PM with a stated reason of "News pending."January 31, 2024 | marketbeat.comGeoVax, Inc.: GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid RequirementJanuary 29, 2024 | finanznachrichten.deEQS-News: GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid RequirementJanuary 29, 2024 | markets.businessinsider.comGeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid RequirementJanuary 29, 2024 | finance.yahoo.comGeoVax Announces Gedeptin® Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer PatientsJanuary 4, 2024 | finance.yahoo.comGeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2024December 27, 2023 | finance.yahoo.comGeoVax, Inc.: GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and SmallpoxDecember 19, 2023 | finanznachrichten.deGeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and SmallpoxDecember 19, 2023 | finance.yahoo.comProgress on GeoVax’s Universal Coronavirus Vaccine Candidate, GEO-CM02, Presented at Vaccines Summit 2023November 14, 2023 | finance.yahoo.comGeoVax Reports Third Quarter 2023 Financial Results and Provides Business UpdateNovember 8, 2023 | finance.yahoo.comGeoVax Commences Site Expansion for Phase 2 Trial of Next-Generation COVID-19 VaccineOctober 30, 2023 | finance.yahoo.comGeoVax to Participate in Upcoming November Investor and Industry EventsOctober 25, 2023 | finance.yahoo.comGeoVax Receives Notice of Allowance for Marburg Vaccine PatentOctober 9, 2023 | finance.yahoo.comGeoVax Receives Notice of Allowance for HIV Vaccine PatentOctober 5, 2023 | finance.yahoo.comGeoVax Secures Multi-Product License for ProBioGen's AGE1.CR.pIX® Suspension Cell Line to Bolster MVA-Based Vaccine DevelopmentSeptember 26, 2023 | finance.yahoo.comGeoVax Next-Generation COVID-19 Vaccine Data Presented at Keystone Symposia ConferenceSeptember 20, 2023 | finance.yahoo.comGeoVax to Present at the Emerging Growth Conference on September 6, 2023August 29, 2023 | finance.yahoo.comGeoVax Announces First Patients Vaccinated in Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic LeukemiaAugust 10, 2023 | finance.yahoo.comGeoVax Reports 2023 Second Quarter Financial Results and Provides Corporate UpdateAugust 9, 2023 | finance.yahoo.comGeoVax Labs Shares Rise 8% After Patent for Ebola VaccineJuly 24, 2023 | marketwatch.comGOVX - GeoVax Labs, Inc.July 11, 2023 | finance.yahoo.comGeoVax Presents Gedeptin® Clinical Data at the AACR-AHNS Head and Neck Cancer ConferenceJuly 10, 2023 | finance.yahoo.comGeoVax’s Next-Generation COVID-19 Vaccine Shows High Immunogenicity in Immunocompromised PatientsMay 24, 2023 | finance.yahoo.comGeoVax Labs to Participate in A.G.P.’s Virtual Healthcare ConferenceMay 9, 2023 | finance.yahoo.comAnalysts Offer Insights on Healthcare Companies: GeoVax Labs (GOVX), Selecta Biosciences (SELB) and Assembly Biosciences (ASMB)May 8, 2023 | markets.businessinsider.comGeoVax to Participate in the 4th Symposium on Infectious Diseases in the Immunocompromised HostApril 26, 2023 | finance.yahoo.comGeoVax to Host First Quarter 2023 Business Update and Financial Results Conference Call on May 4, 2023April 25, 2023 | finance.yahoo.comGeoVax, Inc.: GeoVax Announces Presentation of Preliminary Data from Clinical Trial of Next-Generation COVID-19 Vaccine CandidateApril 6, 2023 | finanznachrichten.deGeoVax Labs, Inc. (NASDAQ:GOVX) Q4 2022 Earnings Call TranscriptMarch 27, 2023 | finance.yahoo.comGeoVax, Inc.: GeoVax Reports 2022 Year-End Financial Results and Provides Corporate UpdateMarch 24, 2023 | finanznachrichten.deGeoVax Announces Decisive Progress in Establishing High-Capacity, Continuous Cell Line System to Manufacture MVA-based VaccinesFebruary 8, 2023 | finance.yahoo.comGeoVax Reports 2022 Third Quarter Financial Results and Provides Corporate UpdateNovember 9, 2022 | finance.yahoo.comGeoVax to Host Third Quarter 2022 Business Update and Financial Results Conference Call on November 9, 2022October 26, 2022 | finance.yahoo.com Get GeoVax Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for GOVXW and its competitors with MarketBeat's FREE daily newsletter. Email Address New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention. 👉 Click here to access your FREE report now! GOVXW Media Mentions By Week GOVXW Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GOVXW News Sentiment▼0.450.46▲Average Medical News Sentiment GOVXW News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GOVXW Articles This Week▼20▲GOVXW Articles Average Week Get GeoVax Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for GOVXW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Alvotech News Today biote News Today BriaCell Therapeutics News Today Clever Leaves News Today Fortress Biotech News Today LAVA Therapeutics News Today Mainz Biomed News Today Pharvaris News Today Procaps Group News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GOVXW) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GeoVax Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GeoVax Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GOVXW Stock Alerts